Wayne Jiang

Person

Waltham, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Immune modulation with TLR9 agonists for cancer treatment
- Patent number 11,224,611
- Issue date Jan 18, 2022
- IDERA PHARMACEUTICALS, INC.
- Sudhir Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immune modulation with TLR9 agonists for cancer treatment
- Patent number 10,835,550
- Issue date Nov 17, 2020
- IDERA PHARMACEUTICALS, INC.
- Sudhir Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immune modulation with TLR9 agonists for cancer treatment
- Patent number 10,772,907
- Issue date Sep 15, 2020
- IDERA PHARMACEUTICALS, INC.
- Sudhir Agrawal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immune modulation with TLR9 agonists for cancer treatment
- Patent number 10,463,686
- Issue date Nov 5, 2019
- IDERA PHARMACEUTICALS, INC.
- Sudhir Agrawal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions for inhibiting checkpoint gene expression and uses the...
- Patent number 9,828,601
- Issue date Nov 28, 2017
- Idera Pharmaceuticals, Inc.
- Sudhir Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT
- Publication number 20220088054
- Publication date Mar 24, 2022
- IDERA PHARMACEUTICALS, INC.
- Sudhir AGRAWAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT
- Publication number 20210052625
- Publication date Feb 25, 2021
- IDERA PHARMACEUTICALS, INC.
- Sudhir AGRAWAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT
- Publication number 20210038630
- Publication date Feb 11, 2021
- IDERA PHARMACEUTICALS, INC.
- Sudhir AGRAWAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT
- Publication number 20200138848
- Publication date May 7, 2020
- IDERA PHARMACEUTICALS, INC.
- Sudhir AGRAWAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS
- Publication number 20200101102
- Publication date Apr 2, 2020
- IDERA PHARMACEUTICALS, INC.
- Daqing Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT
- Publication number 20200054663
- Publication date Feb 20, 2020
- IDERA PHARMACEUTICALS, INC.
- Sudhir AGRAWAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT
- Publication number 20180125877
- Publication date May 10, 2018
- IDERA PHARMACEUTICALS, INC.
- Sudhir AGRAWAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR INHIBITING CHECKPOINT GENE EXPRESSION AND USES THE...
- Publication number 20180044669
- Publication date Feb 15, 2018
- IDERA PHARMACEUTICALS, INC.
- Sudhir Agrawal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS
- Publication number 20170274004
- Publication date Sep 28, 2017
- IDERA PHARMACEUTICALS, INC.
- Daqing Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR INHIBITING CHECKPOINT GENE EXPRESSION AND USES THE...
- Publication number 20160251652
- Publication date Sep 1, 2016
- IDERA PHARMACEUTICALS, INC.
- Sudhir Agrawal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS
- Publication number 20160101128
- Publication date Apr 14, 2016
- IDERA PHARMACEUTICALS, INC.
- Daqing Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Wayne Jiang

Person

Patents Grantslast 30 patents

Immune modulation with TLR9 agonists for cancer treatment

Immune modulation with TLR9 agonists for cancer treatment

Immune modulation with TLR9 agonists for cancer treatment

Immune modulation with TLR9 agonists for cancer treatment

Compositions for inhibiting checkpoint gene expression and uses the...

Patents Applicationslast 30 patents

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

COMPOSITIONS FOR INHIBITING CHECKPOINT GENE EXPRESSION AND USES THE...

TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS

COMPOSITIONS FOR INHIBITING CHECKPOINT GENE EXPRESSION AND USES THE...

TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS